This filing details transactions by Jianxiang Zhou, Chief Technology Officer of Cheche Group Inc. On March 1, 2024, and March 31, 2025, Mr. Zhou was granted stock options to purchase 3,000 shares of Class A Common Stock each, under the 2019 Equity Incentive Plan. These options are fully vested upon grant and become exe...

This filing details a Power of Attorney granted by Shih-Jye Cheng, an officer and director of CHIPMOS TECHNOLOGIES INC., to Hsiu-Ling Teng and I-Fan Kung. The attorneys-in-fact are authorized to act on Mr. Cheng's behalf for all necessary actions related to submitting and filing forms, schedules, and other documents wi...

This filing details the initial ownership report (Form 3) for John Simon Fraser, an officer and/or director of CoastalSouth Bancshares, Inc. (COSO). The report includes information on derivative holdings, specifically Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis and vest fully on De...

This filing details a Form 3, Initial Statement of Beneficial Ownership, for Dafna Sharir, a director at Cognyte Software Ltd. The filing indicates that following a transaction, Sharir beneficially owns 126,450 ordinary shares. This total includes shares represented by restricted stock units (RSUs) granted on March 24,...

This filing reports that Earl C. Shanks, a director at Cognyte Software Ltd. (CGNT), has a direct ownership of 293,075 ordinary shares. The filing includes details about restricted share units (RSUs) granted on March 24, 2025, and March 16, 2026. The RSUs granted on March 24, 2025, totaling 19,048 shares, are set to ve...

This filing details the ownership of Matthew K. O'Neill, a director at Cognyte Software Ltd. (CGNT), as of March 16, 2026. The filing indicates that O'Neill directly owns 40,022 ordinary shares. This total includes 19,048 ordinary shares represented by restricted share units (RSUs) granted on March 24, 2025, which vest...

This filing is an initial report of beneficial ownership on Form 3 for Efi Nuri, Chief Revenue Officer of Cognyte Software Ltd. The report details Nuri Efraim's ownership of 611,676 ordinary shares, including shares represented by restricted share units (RSUs) and performance share units (PSUs) granted on various dates...

This Form 3 filing reports the initial ownership of Cognyte Software Ltd. (CGNT) by director Sharon Elad as of March 16, 2026. The filing discloses ownership of 2,167,671 ordinary shares, which includes various equity awards. The holdings consist of 43,367 RSUs granted September 2023 (vesting May 2026), 297,470 PSUs gr...

This filing reports the initial ownership of securities by Gil Cohen, Chief Product Officer of Cognyte Software Ltd. As of March 16, 2026, Mr. Cohen directly owns 612,445 ordinary shares. The filing also details various restricted share units (RSUs) and performance share units (PSUs) granted to Mr. Cohen, with vesting ...

Ron Shvili, a director at Cognyte Software Ltd., has filed a Form 4, reporting a change in beneficial ownership. The filing details 75,853 ordinary shares following a transaction, which includes restricted share units granted on May 1, 2024, March 24, 2025, and March 16, 2026. These RSUs are subject to vesting schedule...

This filing reports the initial ownership of securities by Gil Cohen, Chief Product Officer of Cognyte Software Ltd. As of March 16, 2026, Mr. Cohen directly owns 612,445 ordinary shares. The filing also details various restricted share units (RSUs) and performance share units (PSUs) granted to Mr. Cohen, with vesting ...

This filing reports the ownership of securities by Jean I Liu, a director at Connect Biopharma Holdings Ltd. The report details holdings of stock options, which are derivative securities. Several stock options are listed with their respective exercise dates, expiration dates, and conversion/exercise prices. These optio...

This filing, a Form 3, reports initial beneficial ownership of securities for Karen J. Wilson, a director at Connect Biopharma Holdings Ltd. The filing details direct holdings of ordinary shares amounting to 10,000 shares. Additionally, it discloses various stock options to purchase ordinary shares, with exercise price...

This filing details Barry D. Quart's ownership of Connect Biopharma Holdings Ltd. securities. As of March 16, 2026, Quart directly owns 95,147 ordinary shares and indirectly owns an additional 128,887 ordinary shares through a joint account with his spouse. The filing also discloses several stock options granted to Qua...

This filing reports on derivative holdings for James A. Schoeneck, a director at Connect Biopharma Holdings Ltd. The report details two stock options: one with an exercise price of $2.38 and an expiration date of July 22, 2035, for 120,000 ordinary shares, subject to vesting over three years. The second stock option ha...

This filing details the ownership of securities by David Leslie Szekeres, President of Connect Biopharma Holdings Ltd. As of March 16, 2026, Mr. Szekeres directly holds 215,739 ordinary shares. The filing also reports on various employee stock options granted to him, with different vesting schedules and expiration date...

This SEC Form 3 filing reports the initial statement of beneficial ownership for Lisa Peraza, Senior Vice President of Finance at Connect Biopharma Holdings Ltd (CNTB). The filing discloses Peraza's ownership of 45,189 ordinary shares and multiple stock option grants. The options include: 400,000 shares at $1.15 expiri...

This filing details the ownership of securities by reporting owner Kleanthis Gabriel Xanthopoulos, who is a director at Connect Biopharma Holdings Ltd. The filing indicates direct ownership of 80,000 ordinary shares. Additionally, it outlines various stock options with different exercise prices and expiration dates, al...

This filing details the ownership of CooTek(Cayman)Inc. (CTKYY) by ZHANG KAN, who holds the positions of CTO and Acting CFO. The filing indicates direct ownership of 94,285,750 Class A ordinary shares. Additionally, indirect ownership of 246,224,465 Class B ordinary shares is held through Kan's Global CoolStuff Investm...

This Form 3 filing discloses that Wai Leung Alfred Lau, an Independent Director of Creative Global Technology Holdings Ltd (CGTL), has filed an initial statement of beneficial ownership. The filing, dated March 16, 2026, reports that as of the period ending November 18, 2024, Mr. Lau holds no securities in the company....

This is a Form 3 filing by JiaYun Hong, reporting initial beneficial ownership in Creative Global Technology Holdings Ltd (CGTL). Hong serves as both a director and the Chief Operations Officer of the company. The filing indicates that as of the reporting date of November 18, 2024, Hong owns no securities in the compan...

This is a Form 3 initial statement of beneficial ownership filing for Creative Global Technology Holdings Ltd (CGTL). The filing reports that Hei Tung Siu, who serves as both Chief Executive Officer and Chairman of the Board of Directors, has no securities owned in the company as of November 18, 2024. The filing was si...

This filing reports that Liao Xin Yu, an Independent Director of Creative Global Technology Holdings Ltd (CGTL), has no securities owned as of November 18, 2024. The filing date was March 16, 2026....

This filing indicates that Stephen CuUnjieng, a director at Apex Treasury Corp, has granted power of attorney to Tomisin Ogunsanya and others. This allows them to act on his behalf regarding SEC filings, including Forms 3, 4, 5, Schedules 13D, 13G, and Form 144. The attorneys-in-fact are authorized to manage EDGAR acco...

This SEC Form 3 filing reports that Shi Wei Lay, a director of Delixy Holdings Ltd (ticker: DLXY), held no securities in the company as of December 31, 2025. The filing, signed on March 13, 2026, indicates that Shi Wei Lay is a director based in Singapore but does not own any shares or derivative securities in the comp...